<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03726320</url>
  </required_header>
  <id_info>
    <org_study_id>18-00514</org_study_id>
    <secondary_id>1R01MD012243-01A1</secondary_id>
    <nct_id>NCT03726320</nct_id>
  </id_info>
  <brief_title>Trial of Community Health Worker-led Decision Coaching</brief_title>
  <official_title>Randomized Trial of Community Health Worker-led Decision Coaching to Promote Shared Decision Making for Prostate Cancer Screening Among Black Male Patients and Their Providers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Minority Health and Health Disparities (NIMHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Black men are disproportionately affected by prostate cancer, the most common non-cutaneous
      malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a
      Community Health Worker-led decision coaching program to facilitate Shared Decision Making
      (SDM) and Prostate Specific Antigen (PSA) screening among Black men with regards to decision
      quality, the decision making process, patient-provider communication and PSA utilization for
      Black men in the primary care setting.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decision Self-Efficacy Scale</measure>
    <time_frame>9 Months</time_frame>
    <description>11 item scale measuring self-efficacy to perform informed decision making (e.g. getting needed information, asking questions, expressing opinions, and asking for advice)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prostate Specific Antigen (PSA) screening Rates</measure>
    <time_frame>5 Years</time_frame>
    <description>PSA rates collected through patient self-reported PSA testing and EHR data on PSA test utilization</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a decision aid along with decision coaching on PSA screening from a Community Health Worker (CHW)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a decision aid along with CHW interaction on dietary and lifestyle modification to serve as an attention control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education Counseling Session for PSA Screening</intervention_name>
    <description>counseling from extensively trained CHW</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>General Health Counseling Coaching</intervention_name>
    <description>coaching using an educational tool focused on dietary and lifestyle modification</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients:

          -  Black

          -  Male

          -  Attending FQHC for routine primary care appointment

        Providers:

          -  Provider at Sunset Park Health Council Federally Qualified Health Center (FQHC)

          -  Caring for patients that fit inclusion criteria

        Exclusion Criteria:

          -  Provider at Sunset Park Health Council Federally Qualified Health Center (FQHC)

          -  Caring for patients that fit inclusion criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Gender Identity</gender_description>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danil Makarov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shannon Ciprut</last_name>
    <phone>646 501 2938</phone>
    <email>shannon.ciprut@nyumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Natalia Martinez-Lopez</last_name>
    <email>Natalia.Martinez-lopez@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Ciprut</last_name>
      <phone>646-501-2938</phone>
      <email>shannon.ciprut@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Danil Makarov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 7, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Aggregate participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Immediately following publication. No end date.</ipd_time_frame>
    <ipd_access_criteria>Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting requests and accessing data may be found at (Link to be provided).Researchers who provide a methodologically sound proposal will have access to the data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

